Lack of pharmacokinetic drug interaction between tenofovir disoproxil fumarate and nelfinavir mesylate

被引：16
|
作者：
Boffito, M
Pozniak, A
Kearney, BP
Higgs, C
Mathias, A
Zhong, LJ
Shah, J
机构：
[1] Chelsea & Westminster Hosp, PK Res, St Stephens Ctr, London SW10 9NH, England
[2] Gilead Sci Inc, Foster City, CA USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 10期
关键词：
D O I：
10.1128/AAC.49.10.4386-4389.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A study explored the pharmacokinetics of tenofovir (300 mg administered once daily) and nelfinavir (1,250 mg twice daily) when coadministered in 29 healthy volunteers. Tenofovir, nelfinavir, and M8 pharmacolkinetics was unaltered when tenofovir and neltinavir were coadministered, and tenofovir administration did not affect the M8/nelfinavir area under the concentration-versus-time curve over the dosing interval (AUC(tau)) ratio. No interaction between tenofovir and nelfinavir was observed.
引用
收藏
页码：4386 / 4389
页数：4
相关论文
共 50 条
  • [1] Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers
    Hoetelmans, Richard M. W.
    Marien, Kris
    De Pauw, Martine
    Hill, Andrew
    Peeters, Monika
    Sekar, Vanitha
    De Doncker, Piet
    Woodfall, Brian
    Lefebvre, Eric
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (05) : 655 - 661
  • [2] Lack of pharmacokinetic interaction between nelfinavir and nevirapine
    Skowron, G
    Leoung, C
    Kerr, B
    Dusek, A
    Anderson, R
    Beebe, S
    Grosso, R
    AIDS, 1998, 12 (10) : 1243 - 1244
  • [3] Lack of a Clinically Meaningful Drug Interaction Between the HIV-1 Antiretroviral Agents Islatravir, Dolutegravir, and Tenofovir Disoproxil Fumarate
    Rudd, Deanne Jackson
    Zhang, Saijuan
    Fillgrove, Kerry L.
    Fox-Bosetti, Sabrina
    Matthews, Randolph P.
    Friedman, Evan
    Armas, Danielle
    Stoch, S. Aubrey
    Iwamoto, Marian
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (12): : 1432 - 1441
  • [4] Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/emtricitabine and abacavir/lamivudine
    Vourvahis, Manoli
    Davis, John
    Langdon, Grant
    Layton, Gary
    Fang, Juanzhi
    Choo, Heng Wee
    Hansson, Arne G.
    Tawadrous, Margaret
    ANTIVIRAL THERAPY, 2013, 18 (06) : 745 - 754
  • [5] Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects
    Lee, Sangmi
    Kim, Eunwoo
    Moon, Seol Ju
    Jung, Jina
    Lee, SeungHwan
    Yu, Kyung-Sang
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (01) : 45 - 52
  • [6] Lack of Effect of Tenofovir Disoproxil Fumarate on Pharmacokinetics of Hormonal Contraceptives
    Kearney, Brian P.
    Mathias, Anita
    PHARMACOTHERAPY, 2009, 29 (08): : 924 - 929
  • [7] LACK OF PHARMACOKINETIC INTERACTION BETWEEN CIMETIDINE AND TIRILAZAD MESYLATE
    FLEISHAKER, JC
    HULST, LK
    PETERS, GR
    PHARMACEUTICAL RESEARCH, 1994, 11 (02) : 341 - 344
  • [8] Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine
    Kearney, BP
    Sayre, JR
    Flaherty, JF
    Chen, SS
    Kaul, S
    Cheng, AK
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (12): : 1360 - 1367
  • [9] Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers
    Droste, JAH
    Verweij-van Wissen, CPWGM
    Kearney, BP
    Buffels, R
    vanHorssen, PJ
    Hekster, YA
    Burger, DM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) : 680 - 684
  • [10] Emtricitabine/tenofovir disoproxil fumarate/tacrolimusFanconi Syndrome following drug-drug interaction: case report
    Reactions Weekly, 2021, 1881 (1) : 110 - 110
12345